Kabra Drugs Ltd

AGM Details

• AGM held on 30 September 2026 at 09:00 AM, physical at Chennai hotel.
• Remote e-voting from 27 to 29 September 2026; poll conducted at AGM.
• Chair: Mr. K N Anand, Executive Director.

Key Resolutions

• Adoption of Audited Financial Statements and reports for year ended 31 March 2026.
• Re-appointment by rotation of Mr. Kuniamuthur Nanjappan Anand (DIN: 03230186).
• Appointment of Moonam Kapoor as Additional Non-Executive Independent Director (Apr 21, 2026–Apr 20, 2031).
• Appointment of Twinkle Agarwal, Practising Company Secretary, for five-year term (2026–2031).

Director Changes

• Moonam Kapoor appointed as Additional Non-Executive Independent Director (to 2031).

Auditors

• No changes to statutory, secretarial, or cost auditors disclosed.

Voting Status

• Voting results to be announced within 48 hours.

Kabra Drugs Ltd: Trading Window closed from 01st October 2026 till the expiry of 48 hours after the declaration of unaudited Financial Results of the Company for the quarter ended 30th September 2026.

Financial performance

• Revenue from operations: 9,274.00 lakh in FY2025-26.
• Total revenue: 9,323.27 lakh; prior year 64.02.
• Profit before tax: 572.07 lakh.
• Profit after tax: 495.98 lakh; EPS 2.09.
• Tax expense: 76.09 lakh; current 75.54 and deferred 0.55.
• Dividends: no dividend declared.
• Net cash flow from operations: -946.09 lakh.
• Total assets: 8,631.56 lakh; cash 1,058.23.
• Trade receivables: 7,077.60; trade payables: 5,487.98.
• Share capital: 2,370.79 lakh; 23,707,850 shares.

Transformation & strategy

• Name changed to Aanjaay Industries Limited, effective 6 July 2026.
• Moved corporate base to Chennai for efficiency.
• Pivoted to diversified trading, procurement, industrial supply.
• Resumed commercial activities; trading turnover generated; cash flows improved.
• Revenue recognition aligned with Ind AS 115 for manufacturing with trading.

Governance & management changes

• Moonam Kapoor appointed Independent Director from 21 Apr 2026.
• Ritu Tiwari and Nikita Sinha appointed Independent Directors from 8 Oct 2025.
• Pavanasam appointed CFO from 8 Oct 2025; Bangalore Venkatakrishnappa resigned as WTD & CFO.
• Twinkle Agarwal appointed Secretarial Auditor for 2026-2031.
• Audit committee chaired by Moonam Kapoor from Oct 2025.
• Resignations: Anand Anitha (Aug 12, 2026) and Shilpa (Oct 8, 2025).
• Board met 11 times in 2025-26; independent directors held separate meeting Mar 7, 2026.

Audit, risk & internal controls

• Auditors: PPN & Company; term to 2028-29.
• Key audit matter: revenue recognition under Ind AS 115.
• Going concern: negative cash flow; assessed via forecasts.
• Trade receivables risk; significant balance; no loss allowance recognized.
• Trade payables: large; reviewed procurement and liabilities.
• Related party transactions: arm's length; disclosed per IND AS 24.
• Internal controls: adequate; MR-3 annexed; secretarial audit changes.

Shareholder & market info

• AGM: 30 Sept 2026; book closure 24-30 Sept 2026.
• Listing: BSE; Scrip 524322; ISIN INE323K01017.
• Shareholding as of 31 Mar 2026: 23.7 million shares; 80.64% held by large holders.
• RTA: Skyline Financial Services; transfers processed timely.
• Board composition: eight directors; 50% independent; diverse governance.

Outlook & risks

• Aim to consolidate corporate turnaround; pursue growth in existing and new sectors.
• Risks include competition, policy changes, raw material prices, macro conditions.
• Opportunities in partnerships, new products, and technologies to sustain growth.

AGM Details

• Date/time: 30 September 2026, 09:00 AM, physical at Fairfield by Marriott, Chennai.
• Venue: Fairfield by Marriott Hotel, 169 Rajiv Gandhi Salai, Semmancheri, Chennai.
• Book closure: 24 Sep 2026 to 30 Sep 2026 (inclusive).
• EVoting window: 27 Sep 2026 09:00 to 29 Sep 2026 17:00; cut-off 23 Sep 2026.

Resolutions

• Resolution 1 (Ordinary): Adopt Audited Financial Statements for year ended 31 March 2026; voting results pending.
• Resolution 2 (Ordinary): Re-appoint Kuniamuthur Nanjappan Anand as Director on rotation; results pending.
• Resolution 3 (Ordinary): Appoint Moonam Kapoor as Non-Executive Independent Director for five years; results pending.
• Resolution 4 (Ordinary): Appoint Twinkle Agarwal as Secretarial Auditor for five years; results pending.

Director Changes

• Moonam Kapoor appointed as Non-Executive Independent Director for five-year term from 21 April 2026.
• Kuniamuthur Nanjappan Anand to be re-appointed as Director on rotation.

Auditor Appointments

• Twinkle Agarwal appointed as Secretarial Auditor for 2026-27 to 2030-31.

Appointment of internal auditor

• Kabra Drugs Ltd appoints Karthik L & Associates Chartered Accountants as internal auditor for FY 2026-27.
• Appointment pursuant to Regulation 30 of SEBI LODR 2015 and Companies Act 2013.
• Date of appointment: 2 September 2026.
• Annexure A contains profile of the auditor; FRN 024924S.
• Company states the appointment to comply with regulatory requirements.

Appointment of Secretarial Auditor

• Twinkle Agarwal appointed as Secretarial Auditor for FY2026-27 to 2027-31.
• Disclosure under Regulation 30 SEBI LODR to comply with Companies Act and listing norms.
• Date of appointment: 02 September 2026; terms cover 2026-27 to 2027-31.
• Company renamed as Aanjaay Industries Limited (formerly Kabra Drugs Limited).

Governance and AGM approvals

• Director's Report and Corporate Governance Report for FY ended 31 March 2026 approved.
• Notice of 37th AGM approved for 30 September 2026 in Chennai.
• Scrutinizer appointed for AGM.
• Re-appointment of Director Kuniamuthur Nanjappan Anand, retiring by rotation.
• Internal Auditor appointed: M/s Karthik L & Associates for FY 2026-27.
• Ms. Moonam Kapoor appointed as Director.
• Secretarial Auditor appointed for five financial years 2026-27 to 2030-31.

Shareholding, E-voting and AGM dates

• Register of Members and Share Transfer Register to close 24-30 September 2026.
• Cut-off date fixed at 23 September 2026; book closure 24-30 September 2026.
• E-voting from 27 September 2026 09:00 AM to 29 September 2026 05:00 PM.

Change in Registered Office Address

• Previous registered office: 208 Swadesh Bhavan, 2 Press Complex, AB Road, Indore, Madhya Pradesh-452011.
• New registered office: No. 3, 2nd Floor, Swaminathan Street, West Mambalam, Chennai-600033.
• Effective date: 28 August 2026.
• Change involves relocation to a different state and ROC (Indore, MP to Chennai, TN).
• Reasons: board approval; regional director and ROC clearance; statutory compliances completed.
• Impact: future correspondence will be addressed to the new registered office.

Meeting Details

• Board meeting scheduled for 2 September 2026 at the Corporate Office, Chennai.

Key Agenda Items

• Approve Director’s Report and Corporate Governance Report for FY ended 31 March 2026.
• Approve AGM-related items: closure of Register of Members and Share Transfer Books, cutoff date, and AGM notice.
• Approve appointment of Scrutinizer for AGM.
• Recommend re-appointment of Mr. Kuniamuthur Nanjappan Anand (DIN: 03230186) retiring by rotation.
• Approve appointment of Internal Auditors for FY 2026-27.
• Recommend appointment of Ms. Moonam Kapoor as Director.
• Recommend appointment of Secretarial Auditor for FY 2026-27 to 2030-31.